Dementia News and Research

Latest Dementia News and Research

Depressive symptoms among caregivers increase substantially before the onset of dementia in partners

Depressive symptoms and caregiving hours among older adults caring for partners with dementia can emerge up to 10 years before a routine screening detects the first signs of their partner’s cognitive impairment, according to a University of Michigan study.

8 Sep 2022

New tool uses artificial intelligence to calculate harmful effects of medicines

Research led by the University of Exeter and Kent and Medway NHS and Social Care Partnership Trust, published in Age and Ageing, assessed a new tool designed to calculate which medicines are more likely to experience adverse anticholinergic effects on the body and brain.

7 Sep 2022

Older people with insomnia more likely to develop memory decline, finds study

A new Canadian study has found that older people with insomnia are at greater risk of developing memory decline and long-term cognitive impairment such as dementia.

6 Sep 2022

Studies show link between OSA and decline in mental processing powers, increased risk of blood clots, cancer

People who suffer from obstructive sleep apnea (OSA) are at an increased risk of cancer, according to a large study presented on Monday at the European Respiratory Society International Congress in Barcelona, Spain.

5 Sep 2022

Researchers secure $20.5 million NIH grant to beat Alzheimer's disease and related dementias

A team of researchers at the University of Kentucky's Sanders-Brown Center on Aging has been awarded a $20.5 million grant from the National Institute on Aging of the National Institutes of Health.

2 Sep 2022

Type 2 diabetes remission achieved more effectively with bariatric surgery than lifestyle changes

Remission of type 2 diabetes is achieved more effectively and has longer-lasting results with bariatric surgery than through medications and lifestyle changes.

1 Sep 2022

The currently available evidence on viral-induced parkinsonism

A new review attempts to summarize all known about the relationship between viral illness and parkinsonian disorders to facilitate further research.

31 Aug 2022

The prevalence and risk factors for delirium in older patients hospitalized with COVID-19

A recent study explored what determined the risk of delirium in older patients hospitalized with COVID-19 and the outcomes of this hospitalization.

31 Aug 2022

Research shows how sensor-based health monitoring could help tackle age-related health problems

Specific changes in our movement patterns can be indicators of several health problems: For instance, decrease in strength often correlates with risk of falls, mild cognitive impairment, depression, sleep problems, respiratory problems, cardiac arrhythmias and increasing myocardial weakness or worsening of a COVID-19 infection.

30 Aug 2022

In vivo imaging of α-synuclein aggregates in the brains of living patients with multiple system atrophy

α-synuclein is a neuronal protein involved in functions like vesicle trafficking and neurotransmitter release. It is typically found in abundance in a healthy brain.

30 Aug 2022

Study moves one step closer to providing a more efficient treatment for age-related memory loss

According to the Alzheimer's Association, an estimated 6.5 million Americans aged 65 and older are living with Alzheimer's in 2022. That figure is predicted to nearly double by 2050.

29 Aug 2022

Regenstrief research scientist voted president-elect of the American Delirium Society

Regenstrief Research Scientist Noll Campbell, PharmD, M.S., has been voted president-elect of the American Delirium Society (ADS) by the board of directors. Dr. Campbell will be installed into office in conjunction with the society's national conference in June of 2023.

29 Aug 2022

Music intervention can help bridge the gap between dementia patients and their loved ones

People with dementia often lose their ability to communicate verbally with loved ones in later stages of the disease.

29 Aug 2022

FAU and Tel Aviv researchers receive grant to tackle Alzheimer’s-related mood disorders

Alzheimer's disease (AD) is the most common type of dementia affecting an estimated 6.3 million Americans age 65 and older. Without the development of medical breakthroughs to prevent, treat, slow or cure AD that number could grow to 13.8 million by 2060.

29 Aug 2022

EPFL scientists uncover key mechanisms underlying the formation of protein tangles in the brain

Neurodegenerative disorders such as Alzheimer's and Parkinson's disease are associated with atypical proteins that form tangles in the brain, killing neurons.

29 Aug 2022

Penn State receives $1.6 million grant to study the link between COVID-19 and cognitive decline

As populations around the globe age, dementia -; often caused by Alzheimer's disease and related disorders -; is a growing health issue for older adults worldwide.

26 Aug 2022

Weill Cornell Medicine laryngologist wins Paul B. Beeson Emerging Leaders Career Development Award in Aging

Dr. Anaїs Rameau, an assistant professor of otolaryngology and an attending laryngologist at the Sean Parker Institute for the Voice at Weill Cornell Medicine, has been awarded a Paul B. Beeson Emerging Leaders Career Development Award in Aging by the National Institute on Aging, the American Federation for Aging Research and the John A. Hartford Foundation.

26 Aug 2022

Sacubitril/valsartan does not change cognitive function in patients with heart failure

Sacubitril/valsartan does not change cognitive function, compared with valsartan, in patients with heart failure and mildly reduced or preserved ejection fraction, according to late breaking research presented in a Hot Line session today at ESC Congress 2022.

26 Aug 2022

Brain stimulation improves memory function in older adults

Researchers evaluate the effectiveness of repetitive neuromodulation in improving the working memory and long-term memory of older adults.

25 Aug 2022

New diagnoses of neurological and psychiatric disorders remain common two years after COVID-19

New diagnoses of disorders including psychosis, dementia, seizures and ‘brain fog’ remain commoner two years after COVID-19 than after other respiratory infections, whereas the increased risks of depression and anxiety after COVID-19 are short-lived and there is no overall excess of cases.

25 Aug 2022

Dementia News and Research

Latest Dementia News and Research

Depressive symptoms among caregivers increase substantially before the onset of dementia in partners

New tool uses artificial intelligence to calculate harmful effects of medicines

Older people with insomnia more likely to develop memory decline, finds study

Studies show link between OSA and decline in mental processing powers, increased risk of blood clots, cancer

Researchers secure $20.5 million NIH grant to beat Alzheimer's disease and related dementias

Type 2 diabetes remission achieved more effectively with bariatric surgery than lifestyle changes

The currently available evidence on viral-induced parkinsonism

The prevalence and risk factors for delirium in older patients hospitalized with COVID-19

Research shows how sensor-based health monitoring could help tackle age-related health problems

In vivo imaging of α-synuclein aggregates in the brains of living patients with multiple system atrophy

Study moves one step closer to providing a more efficient treatment for age-related memory loss

Regenstrief research scientist voted president-elect of the American Delirium Society

Music intervention can help bridge the gap between dementia patients and their loved ones

FAU and Tel Aviv researchers receive grant to tackle Alzheimer’s-related mood disorders

EPFL scientists uncover key mechanisms underlying the formation of protein tangles in the brain

Penn State receives $1.6 million grant to study the link between COVID-19 and cognitive decline

Weill Cornell Medicine laryngologist wins Paul B. Beeson Emerging Leaders Career Development Award in Aging

Sacubitril/valsartan does not change cognitive function in patients with heart failure

Brain stimulation improves memory function in older adults

New diagnoses of neurological and psychiatric disorders remain common two years after COVID-19

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Dementia News and Research

Latest Dementia News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in